Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.360
-0.155-2.81%
Volume:499.94K
Turnover:2.61M
Market Cap:4.37B
PE:-22.93
High:5.505
Open:5.300
Low:4.975
Close:5.515
52wk High:9.850
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:2.99
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.234
ROE:-3.45%
ROA:-1.93%
PB:1.03
PE(LYR):-22.93
PS:4.00

Loading ...

Hong Kong IPO Prospectus for Zelgen Biopharmaceutical Lapses

Stock News
·
Jun 22

Targeting the Brain's 'Wake Switch': Alkermes's Narcolepsy Drug Shows Promising Mid-Stage Data, Igniting Race in Orexin Pathway

Stock News
·
Jun 18

HighLight Pharma's Second Hong Kong Listing Bid: Zero Revenue, Pipeline Gaps, and Core Product's Commercial Viability Questioned Under $1.2 Billion Bet Pressure

Deep News
·
Jun 18

ASCLETIS-B Executes Share Buyback Totaling HK$1.97 Million

Stock News
·
Jun 17

Legal Claims Initiated Against Shenwu Energy Saving, Hainan Poly Pharm. Case Resubmitted to Court

Deep News
·
Jun 17

Legal Action Against Puli Pharmaceutical Continues to Gather Momentum, Initial Court Victory Secured

Deep News
·
Jun 17

ASCLETIS-B Executes Share Buyback, Spending HK$1.86 Million

Stock News
·
Jun 16

ASCLETIS-B Executes Share Buyback, Spending HK$1,918,300 on June 15

Stock News
·
Jun 15

ASCLETIS-B Executes HK$1.97 Million Share Buyback on June 11

Stock News
·
Jun 11

ASCLETIS-B Executes Share Buyback, Spending Nearly HK$2 Million

Stock News
·
Jun 10

Biopharmaceutical Firm Reapplies for Hong Kong Listing Amid Ongoing Financial Losses

Stock News
·
Jun 09

Ocumension Sets 30 Jun 2026 AGM; Seeks 20% Issuance Mandate, 10% Buy-back Limit and 8% Option Pool Refresh

Bulletin Express
·
Jun 08

ASCLETIS-B Executes Share Buyback, Spending HK$2 Million on June 8

Stock News
·
Jun 08

PegBio Co-B Shares Surge Over 6% Following Receipt of HKD 61 Million Initial Royalty Payment for Commercialization of Drug Candidate

Stock News
·
Jun 08

ASCLETIS-B Presents Compelling Clinical and Preclinical Data for Obesity Portfolio at ADA 2026, Reinforcing Pipeline Differentiation

Stock News
·
Jun 08

Ocumension Therapeutics (HKG:1477) About To Shift From Loss To Profit

Simply Wall St.
·
Jun 06

PEGBIO CO-B Receives First Commercialization Milestone Payment of HK$61 Million for Weipenataide from Tengrui Pharmaceutical

Stock News
·
Jun 05

Pharmaceutical Sector Rebounds, Huabao Pharma ETF Gains 2% Intraday! Margin Traders Accumulate at Lows, Hong Kong Stock Connect Innovative Drug ETF (520880) Sees Record High Margin Balance!

Deep News
·
Jun 05

ASCLETIS-B Executes Share Buyback Valued at Approximately HK$2.03 Million

Stock News
·
Jun 04

Legal Claim Against Xiangxue Pharmaceutical Filed, Additional Eligible Investors Invited

Deep News
·
Jun 04